NCT06370247View on ClinicalTrials.gov

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

June 25, 2023

Study Completion Date

September 25, 2023

Conditions
SGLT2 Inhibitors, First Time UseType2 DiabetesFasting in Ramadan
Interventions
DIAGNOSTIC_TEST

HbA1c, serum creatinine, eGFR urine analysis and serum electrolyte Na and K

HbA1c, serum creatinine, eGFR urine analysis and serum electrolyte Na and K will measure

Trial Locations (1)

Unknown

Sohag Faculty of Medicine, Sohag

All Listed Sponsors
lead

Sohag University

OTHER